Login

Interview of Alexandre Fraichard, CEO of Genoway 00:00:00

Share On Facebook Share On Twitter

Alexandre Fraichard (genOway)

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Howard Marks of Oaktree Capital Identifies Bargains Amid Market Turbulence
00:00:00
Executive interview – Dr Heikki Lanckriet, CEO, Expedeon
00:10:00
Arbeiten bei 1&1: Ausbildungsleiter Corinna und Felix | Ralph Dommermuth, CEO, 1&1 AG1UX:GER
00:10:00
US Gold Corp CEO George Bee speaks to Proactive's Thomas Warner at Resourcing Tomorrow 2023, Europe's largest mining event in London.|George Bee is CEO of US Gold Corp
00:10:00
Beyond Budgets: The Importance of a Financial Plan
00:10:00
Awale Resources: Strategic Advancements and Promising Exploration in Côte d'Ivoire
00:10:00
Brian invests in most industries outside of biotech and life sciences|Brian Dixon,Partner, Kapor Capital
00:10:00
How to pick a cloud service partner that can grow with you | Stefan Andersson, CEO, Binero Group AB (publ) BINERO:STO
00:10:00
West African Gold Mining Operations Update
00:10:00
Southern Gold's Path to Production and Exploration Ventures: Insights from the One-to-One Conference in London
00:10:00
supporting early stage companies through angel investing|Charley Ma, GM, Fintech at Alloy
00:10:00
Plausible Tomorrows: A Conversation with Vinod Khosla | Vinod Khosla, Founder,  Khosla Ventures.

© 2026 Nehu